Alnylam Pharmaceuticals, Inc 10-K for FY2022
Alnylam Pharmaceuticals, Inc. (ALNY)
10-K
2023-02-23
For: 2022-12-31
View Original
Added on
April 09, 2026
About this 10-K
Alnylam Pharmaceuticals, Inc filed this 10-K on February 23, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.04B
- up 22.9% from $844.29M a year earlier
- Net loss
- $1.13B
- compared with a net loss of $852.82M a year earlier
- Diluted EPS
- -$9.30
- compared with -$7.20 a year earlier